- “Pfizer, Eli Lilly’s recent generics deals signals increasing shift towards emerging markets” (Financial Times)
- “Amgen Buys Exclusive License To Cytokinetics Heart Treatment” (Dow Jones Newswires, CNNMoney.com)
- “Sanofi-Aventis Granted $190 Mln Order from U.S. Health Department to Produce H1N1 Vaccine” (RTT News)
- “FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension “Ahead of the Bell: Vanda surges on Fanapt approval” (Press release issued by United Therapeutics Corporation, PR Newswire)
- “Two-Year Data Reinforce Effect of ACTEMRA(R) (tocilizumab) in Inhibiting Progression of Joint Damage and Improving Physical Function in Rheumatoid Arthritis Patients” (Press release issued by Roche, PR Newswire)
- “Teva resolves patent suit with Cadila Healthcare” (Trading Markets)
- “New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal” (Press release issued by Ortho-McNeil-Janssen Pharmaceuticals, Inc, PR Newswire)
- “Arthritis drug might prove effective in fighting the flu, study suggests” (Press release issued by University of Maryland Medical Center, EurekAlert!)
THE LATEST WORD
Top Industry Stories – May 26, 2009
Posted on May 26th, 2009 | by Rxmedyn | No Comments »Posted in Industry Stories
SUBSCRIBE-
Recent Posts
Archives
Careers | © 2009 Medical Dynamics